Compare MRNA & CLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | CLX |
|---|---|---|
| Founded | 2010 | 1913 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 12.7B |
| IPO Year | 2018 | N/A |
| Metric | MRNA | CLX |
|---|---|---|
| Price | $31.21 | $100.74 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 13 | 11 |
| Target Price | $33.25 | ★ $131.82 |
| AVG Volume (30 Days) | ★ 10.2M | 2.3M |
| Earning Date | 02-13-2026 | 02-02-2026 |
| Dividend Yield | N/A | ★ 4.92% |
| EPS Growth | N/A | ★ 121.91 |
| EPS | N/A | ★ 6.38 |
| Revenue | $2,232,000,000.00 | ★ $6,771,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.17 | $4.80 |
| P/E Ratio | ★ N/A | $15.80 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.28 | $96.66 |
| 52 Week High | $48.92 | $164.22 |
| Indicator | MRNA | CLX |
|---|---|---|
| Relative Strength Index (RSI) | 56.34 | 44.67 |
| Support Level | $29.06 | $96.66 |
| Resistance Level | $31.25 | $101.84 |
| Average True Range (ATR) | 1.58 | 1.81 |
| MACD | -0.24 | 0.40 |
| Stochastic Oscillator | 31.77 | 47.49 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.